Angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin-converting enzyme 2 in patients with cardiovascular disease.
第一作者:
Simon,Lebek
第一单位:
Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
作者:
主题词
老年人(Aged);血管紧张素受体拮抗剂(Angiotensin Receptor Antagonists);血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);冠状动脉分流术(Coronary Artery Bypass);冠状动脉疾病(Coronary Artery Disease);女(雌)性(Female);心力衰竭(Heart Failure);心脏辅助装置(Heart-Assist Devices);血流动力学(Hemodynamics);人类(Humans);白细胞(Leukocytes);男(雄)性(Male);中年人(Middle Aged);心肌(Myocardium);RNA, 信使(RNA, Messenger)
DOI
10.1002/ejhf.2020
PMID
33017071
发布时间
2022-10-05
- 浏览0

European journal of heart failure
2248-2257页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文